277 related articles for article (PubMed ID: 33288545)
1. SLAMF7 Signaling Reprograms T Cells toward Exhaustion in the Tumor Microenvironment.
O'Connell P; Hyslop S; Blake MK; Godbehere S; Amalfitano A; Aldhamen YA
J Immunol; 2021 Jan; 206(1):193-205. PubMed ID: 33288545
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
3. Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy.
Weng J; Wang Z; Hu Z; Xu W; Sun JL; Wang F; Zhou Q; Liu S; Xu M; Xu M; Gao D; Shen YH; Yi Y; Shi Y; Dong Q; Zhou C; Ren N
Cancer Res; 2024 Jun; 84(11):1817-1833. PubMed ID: 38484085
[TBL] [Abstract][Full Text] [Related]
4. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J
Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904
[TBL] [Abstract][Full Text] [Related]
5. PTPN2 regulates the generation of exhausted CD8
LaFleur MW; Nguyen TH; Coxe MA; Miller BC; Yates KB; Gillis JE; Sen DR; Gaudiano EF; Al Abosy R; Freeman GJ; Haining WN; Sharpe AH
Nat Immunol; 2019 Oct; 20(10):1335-1347. PubMed ID: 31527834
[TBL] [Abstract][Full Text] [Related]
6. SLAMF7 modulates B cells and adaptive immunity to regulate susceptibility to CNS autoimmunity.
O'Connell P; Blake MK; Godbehere S; Amalfitano A; Aldhamen YA
J Neuroinflammation; 2022 Oct; 19(1):241. PubMed ID: 36199066
[TBL] [Abstract][Full Text] [Related]
7. Selective elimination of immunosuppressive T cells in patients with multiple myeloma.
Awwad MHS; Mahmoud A; Bruns H; Echchannaoui H; Kriegsmann K; Lutz R; Raab MS; Bertsch U; Munder M; Jauch A; Weisel K; Maier B; Weinhold N; Salwender HJ; Eckstein V; Hänel M; Fenk R; Dürig J; Brors B; Benner A; Müller-Tidow C; Goldschmidt H; Hundemer M
Leukemia; 2021 Sep; 35(9):2602-2615. PubMed ID: 33597728
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
9. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
[TBL] [Abstract][Full Text] [Related]
10. A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma.
Pichler R; Siska PJ; Tymoszuk P; Martowicz A; Untergasser G; Mayr R; Weber F; Seeber A; Kocher F; Barth DA; Pichler M; Thurnher M
Front Immunol; 2023; 14():1095195. PubMed ID: 37006314
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
12. Tumor Cells Hijack Macrophage-Produced Complement C1q to Promote Tumor Growth.
Roumenina LT; Daugan MV; Noé R; Petitprez F; Vano YA; Sanchez-Salas R; Becht E; Meilleroux J; Clec'h BL; Giraldo NA; Merle NS; Sun CM; Verkarre V; Validire P; Selves J; Lacroix L; Delfour O; Vandenberghe I; Thuilliez C; Keddani S; Sakhi IB; Barret E; Ferré P; Corvaïa N; Passioukov A; Chetaille E; Botto M; de Reynies A; Oudard SM; Mejean A; Cathelineau X; Sautès-Fridman C; Fridman WH
Cancer Immunol Res; 2019 Jul; 7(7):1091-1105. PubMed ID: 31164356
[TBL] [Abstract][Full Text] [Related]
13. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients.
Liu T; Xia Q; Zhang H; Wang Z; Yang W; Gu X; Hou T; Chen Y; Pei X; Zhu G; He D; Li L; Xu S
Aging (Albany NY); 2020 Nov; 12(21):21809-21836. PubMed ID: 33177244
[TBL] [Abstract][Full Text] [Related]
14. Signaling Lymphocytic Activation Molecule Family-7 Alleviates Corneal Inflammation by Promoting M2 Polarization.
Zhu S; Chen Y; Lao J; Wu C; Zhan X; Wu Y; Shang Y; Zou Z; Zhou J; Ji X; Huang X; Shi X; Wu M
J Infect Dis; 2021 Mar; 223(5):854-865. PubMed ID: 32702113
[TBL] [Abstract][Full Text] [Related]
15. Immune cell inhibition by SLAMF7 is mediated by a mechanism requiring src kinases, CD45, and SHIP-1 that is defective in multiple myeloma cells.
Guo H; Cruz-Munoz ME; Wu N; Robbins M; Veillette A
Mol Cell Biol; 2015 Jan; 35(1):41-51. PubMed ID: 25312647
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating CD39
Qi Y; Xia Y; Lin Z; Qu Y; Qi Y; Chen Y; Zhou Q; Zeng H; Wang J; Chang Y; Bai Q; Wang Y; Zhu Y; Xu L; Chen L; Kong Y; Zhang W; Dai B; Liu L; Guo J; Xu J
Cancer Immunol Immunother; 2020 Aug; 69(8):1565-1576. PubMed ID: 32306075
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
18. Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.
Comte D; Karampetsou MP; Yoshida N; Kis-Toth K; Kyttaris VC; Tsokos GC
Arthritis Rheumatol; 2017 May; 69(5):1035-1044. PubMed ID: 28076903
[TBL] [Abstract][Full Text] [Related]
19. Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
Mou Y; Wu J; Zhang Y; Abdihamid O; Duan C; Li B
BMC Cancer; 2021 Jan; 21(1):18. PubMed ID: 33402128
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.
Chakraborty B; Byemerwa J; Shepherd J; Haines CN; Baldi R; Gong W; Liu W; Mukherjee D; Artham S; Lim F; Bae Y; Brueckner O; Tavares K; Wardell SE; Hanks BA; Perou CM; Chang CY; McDonnell DP
J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34637400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
